Merck To Take Legal Action Against Unauthorized Distributors For Its COVID Treatments In China

SHANGHAI : Merck & Co said on Wednesday it would take legal action against some pharmaceutical companies after noticing that some manufacturers were supplying COVID-19 drugs to some provinces and cities saying the medicines were authorized by Merck.

It did not name the companies in the post on its official WeChat account in China.

Merck added that Sinopharm is the only legally authorized distributor of Merck’s COVID-19 antiviral molnupiravir in China, which is sold under the brand name Lagevrio and was developed by Merck and partner Ridgeback Biotherapeutics.

It added it had started talks with Sinopharm on the drug’s production technology licence so that Sinopharm can supply the drug in China. Merck said in September that China National Biotec Group, an affiliate of Sinopharm, would make the drug.

China’s abrupt dismantling of its zero-COVID regime starting last month has caught its public off-guard, prompting a hospital scramble for beds and blood and pharmacies to sell out of drugs as a giant wave of infections hit.

The severe shortage of drugs has made many turn to underground channels to secure treatments, which has in turn prompted caution over fake remedies, according to local media reports and social media posts.

Related Posts

  • Pharma
  • March 27, 2024
  • 96 views
Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

Haryana has blacklisted Maiden Pharmaceuticals Ltd, based at Sonepat, for three years, thereby debarring the firm from participating in state tenders. All rate contracts issued to the firm have also…

  • Pharma
  • March 27, 2024
  • 66 views
DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

New Delhi: The Drugs Consultative Committee (DCC), the advisory committee formed by the Central government to advise the Central and state governments on matters that require uniform implementation of drug laws…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

Spurious drugs: Maiden Pharma blacklisted, all contracts cancelled

DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

DCC Calls For Strict Implementation Of Revised Schedule M, State-Level Activities To Address AMR

Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

Sanofi, Cipla Join Hands To Expand Reach Of CNS Portfolio In India

Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

Cyberabad Police Seize 1 Kg Alprazolam, Arrest Three

Lee Health develops natural capsule for effective Heart care

Lee Health develops natural capsule for effective Heart care

Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down

Medical Shop Run By Twenty20 In Kizhakkambalam Asked To Shut Down